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Abstract Stroke is as common as brain tumor in children.
The etiology of childhood arterial ischemic stroke (AIS) ap-
pears to be multifactorial, resulting from the interaction be-
tween genetic predisposition and environmental triggers. The
risk factors for AIS in children are markedly different from the
atherosclerotic risk factors in adults. Trauma and infections
have been identified as associations in previous studies and
are exposures of particular interest because of their increased
prevalence in the children. The aim of this review article is to
provide an overview of the research studies that have ad-
dressed the role of infections and trauma in pediatric AIS.
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Introduction
Pediatric stroke (acute brain injury from a vascular cause)
affects as many children as brain tumor; two-thirds of survi-
vors experience impairments across a range of domains, with
lifelong health, personal, and societal consequences [1]. The
subtypes of childhood stoke are ischemic stroke (arterial
ischemic stroke) and cerebral sinovenous thrombosis), and
nontraumatic intracranial hemorrhage; incidence of these is
roughly equal [2]. Advances in acute treatment and prevention
(both primary and secondary) of childhood stroke have been
hampered by limited understanding of the underlying disease
mechanisms. Specifically, atheromatous cerebrovascular dis-
ease, the commonest disease mechanism in adults, is not
implicated in children, thus, distinct treatment approaches
are likely to be needed. A current view is that childhood AIS
is likely to have a multifactorial etiology that involves inter-
play between host vulnerability (possibly because of geno-
type) and environmental insults [3, 4•]. In this review, we will
focus on 2 common environmental factors, infection and
trauma, and discuss their potential role in the genesis of
childhood AIS.
Risk Factors for Arterial Ischemic Stroke in the Children
Population—an Evolving Understanding
Arterial ischemic stroke (AIS) can be defined as an acute focal
neurologic syndrome because of cerebral infarction in an
arterial distribution. The risk factors for arterial ischemic
stroke (AIS) in children markedly differ from those in adults
[5–7]. A large proportion of children with AIS have another
medical diagnosis that predisposes them to stroke, for exam-
ple sickle cell disease, congenital heart disease, acute systemic
diseases or a range of genetic disorders [5, 6, 8, 9•]. In
addition, comprehensive investigation has identified a large
number of factors that are associated with childhood AIS. The
term ‘risk factor’ has been widely used in the literature to
describe these factors. However, in the absence of case-control
data, direct causality remains unproven in many instances and
it has been suggested that these risk factors are ‘presumptive’
rather than ‘definite’ [8].
Studies of large cohorts have provided complementary data
on presumptive risk factors for childhood AIS. For example, a
study of >200 children from our institution identified
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arteriopathies in >80 % and highlighted a potential role for
trauma and previous chickenpox in children who had been
healthy prior to AIS [6]. Data from a German registry [10]
identified a rather lower rate of arteriopathy (18 %, although
the extent of evaluation was unclear) and a markedly higher
rate of thrombophilia—likely reflecting the genetic makeup of
that population. AIS was attributed to infection in around
10 % of cases. Of note, arteriopathy was significantly associ-
ated with AIS recurrence.
The International Pediatric Stroke Study (IPSS) is an inter-
national collaboration that has enabled analyses of the causes
and consequences of stroke in large cohorts of children. Al-
though hampered by variability in the clinical approach and
completeness of investigation in individual collaborating cen-
ters, the strength of the IPSS is the large multicenter interna-
tional dataset that is available for interrogation. In an analysis
of AIS risk factors in 676 children from 30 centers in 10
countries, the major categories that emerged were
arteriopathies (in >50 %), infection (in around 25 %) cardiac
disorders, acute head and neck disorders, acute systemic con-
ditions (such as sepsis and dehydration), and chronic systemic
conditions (eg, sickle cell disease and connective tissue disor-
ders). In contrast, risk factors for atheroma were rare (in
<2 %). Of note, risk factors were identified in >90 % of cases.
These observations were recently confirmed in a
population-based study of childhood stroke from the south of
England (an area that contains around 50 % of the UK pedi-
atric population). Acute systemic illnesses and arteriopathy
were the two leading risk factor categories identified. Infection
defined as recent infection, acute systemic disorders or acute or
chronic head and neck disorders, was reported at a total fre-
quency of 28 %. Taken together, a common theme that
emerges from these studies is the high rate of arteriopathy
and infection observed in children with AIS.
Cerebral Arteriopathies in Childhood AIS
As previously stated, arteriopathies implicated in childhood
AIS are nonatheromatous. They are currently defined and
categorized on the basis of radiological appearances, usually
on the basis of magnetic resonance angiogram (MRA) find-
ings. The majority of abnormalities are intracranial, although
up to 25 % may have cervical disease [11]. Specific classifi-
cation systems have been proposed to promote consistency in
terminology, initially by Sebire et al (2004) and more recently
the CASCADE system [12]. Specific subtypes of arteriopathy
associated with childhood AIS include moyamoya (occlusive
disease of the terminal internal carotid arteries with basal
collaterals) and arterial dissection.
The most common arteriopathy described in the context of
pediatric AIS is focal occlusive disease of the terminal internal
carotid or proximal middle/anterior cerebral artery. This was
initially termed transient cerebral arteriopathy (TCA) [13].
This is radiologically characterized by unilateral, focal steno-
sis typically of terminal internal carotid artery or proximal
segments of anterior and/or middle cerebral arteries, showing
nonprogression or regression on vascular imaging 6 months
after index AIS [14]. The interval of 6 months is arbitrary, and
there are cases which show improvement after considerably
longer periods [15, 16]. Since many children with AIS are not
re-imaged, in 2009 the IPSS proposed that the term focal
cerebral arteriopathy of childhood (FCA) [17], defined as
previously at presentation, but without the requirement to
show temporal evolution with re-imaging.
Many children with chickenpox preceding AIS, and who
are thought to have post-varicella cerebral infarction, also
have this pattern of arteriopathy. It has been proposed that
the term post-varicella arteriopathy (PVA) is used for these
cases and there is confusion in the literature about the degree
of overlap between FCA and PVA. In fact, these are radiolog-
ically indistinguishable entities, the key difference being the
history of antecedent VZV in the PVA cases. An analysis of
predictors of arteriopathy in the IPSS dataset identified recent
infection, particularly upper respiratory infection, as a strong
predictor of FCA [17]. Thus, it is likely that FCA represents a
focal inflammatory response to a range of infectious agents
(including varicella) and that the association between infec-
tion and arteriopathy in the genesis of childhood AIS is
mediated via the effect of infection on the cerebral circulation.
There is controversy about the possible overlap between
FCA and childhood primary angiitis of the central nervous
system (cPACNS) [18, 19]. The literature contains examples
of patients with indistinguishable clinical presentation and
radiological features, labeled as either FCA or cPACNS. The
difficulty in distinguishing between these two entities arises
from the fact that the patients with FCA fulfil the Calabrese
et al criteria for cPACNS [20], from the lack of sensitivity of
the investigations available for cPACNS and problems asso-
ciated obtaining tissue for histologic diagnosis. Radiological
studies, even catheter angiography, are unlikely to have suffi-
cient resolution to differentiate between an active vs a burnt-
out inflammatory process; however, circulating biomarkers of
endothelial injurymay bemore informative in this regard [21].
In current clinical practice there remain major inconsistencies
in diagnosis and categorization between FCA and cPACNS,
with knock on effects in terms of management.
Mechanisms Linking Infection and Arteriopathy
Several potential biological mechanisms may explain how
infections and inflammation increase the risk of ischemic
stroke [22–25]. Infection could contribute to stroke by pro-
moting systemic procoagulant effects and local inflammation
(or even direct pathogen invasion) of cervical or cerebral
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blood vessels [26]. Disturbances of immune-hematological
mechanisms occur in the context of infection-associated
stroke, including reduced concentrations of circulating anti-
thrombotic protein C, elevated plasma concentrations of C4b-
binding protein S (a main inhibitor of the anticoagulant pro-
tein S), lower ratio of active tissue plasminogen activator to
plasminogen activator inhibitor, and significantly increased
fibrin D-dimer concentration, cardiolipin immunoreactivity,
and fibrinogen concentrations [23, 24, 27]. Increased periph-
eral concentrations of C-reactive protein and pro-
inflammatory cytokines are associated with systemic infection
and can contribute to a procoagulant state by stimulating
monocytes to produce tissue factor [28]. Raised concentra-
tions of IL-6 in adult patients with AIS have been linked to
decreased levels of free protein S, suggesting that IL-6 can
modulate this procoagulant pathway [29]. Infections increase
platelet reactivity and platelet-leukocyte interactions, leading
to an increased risk of platelet aggregation, potentially precip-
itating stroke. Platelet activation (assessed by P-selectin ex-
pression) and platelet-leukocyte aggregates are both increased
in stroke patients [30]. In one study, platelet activation was
increased in 21 stroke patients with history of infection within
1 week of stroke, compared with 37 stroke patients with no
history of infection [30], and increased platelet activation has
also been shown in volunteers with URTI in other study [31].
A study in children has demonstrated that a minor infectious
stimulus in childhood relevant to normal daily life is associ-
ated with endothelial dysfunction, this raising the possibility
that infection may contribute to mechanisms relevant to the
development of early atherosclerosis [32].
As a general response to tissue injury, inflammation is
ubiquitous [22, 33, 34]. As with other tissues, microbial infec-
tion is one trigger for vascular tissue inflammation [35], and
inflammatory cells then subsequently destroy bacteria or virally
infected host cells. Inflammation is also triggered by tissue
trauma not initiated by infection, and this may be relevant when
considering the link between trauma and childhood AIS,
discussed further below. Ideally, the inflammatory response is
short-lived and localized to the site of tissue invasion or trauma.
In contrast, inflammation becomes pathogenic when it occurs at
an inappropriate site, or is excessive in extent or duration [35].
In this context inflammation is a major contributing factor to
many vascular events, including infection-associated stroke and
acceleration of progression of vascular disease.
Infectious Pathogens in Childhood Arterial Ischemic
Stroke
The association between acute infections and childhood AIS
is supported by recent studies, and a number of infectious
pathogens have been linked to stroke in case reports or larger
epidemiologic studies.
A recent case-control study nested within a retrospective
population based cohort of 2.5 million children enrolled in an
integrated health care plan and identified as part of Kaiser
Pediatric Stroke Study (KPSS) in Northern California,
showed that infections are common independent risk factor
for AIS [36]. The study included 126 AIS cases and 378
matched controls, and demonstrated that a minor acute infec-
tion in the 4 weeks prior to the stroke episode increased a
child’s risk of AIS by 4-fold. Major infections (bacteremia/
sepsis within 1 week, and meningitis/encephalitis within
4 weeks prior to infarct) were significantly more prevalent in
the AIS group compared with the controls. However, the most
common infectious diagnoses among the cases were upper
respiratory tract infections, other viral syndromes, acute otitis
media, and acute gastroenteritis; no single type of infection
predominated. Thus, it appears that relatively minor and com-
mon childhood infections are potentially implicated in the
pathogenesis of childhood AIS.
Varicella Zoster (VZV)
VZV is a ubiquitous, exclusively human, DNA virus. After
primary infection (chickenpox), the virus becomes latent in
the ganglionic neurons and can reactivate manifesting with
herpes zoster (shingles). The initial association between child-
hood AIS and a common childhood infection was in the
context of varicella zoster. In 1999, Sebire et al undertook a
case-control study comparing 11 children with AIS to 44
healthy controls. 64 % of children in the AIS group had
varicella at a median of 6 weeks prior to the stroke, vs 9 %
in the control group [37]. In 2001, a Canadian group reported
that 1 in 3 cases of AIS followed varicella in a prospective
cohort study of 70 consecutive children with AIS recruited at
2 institutions [38]. Recently, 2 large studies have brought
further confirmatory evidence on the connection between
VZV and childhood AIS. Thomas et al undertook a self-
controlled case series analysis of data from 4 general practice
databases and found a 4-fold increased risk of stroke in
children within 6 months of chickenpox [39]. A recent retro-
spective cohort study of a large number of herpes zoster cases
and matched controls found that herpes zoster is an indepen-
dent risk factor for vascular disease under 40 years of age in
the UK population [40].
In a review of children with VZVassociated AIS, common
features were that these tended to be younger, otherwise
healthy children, with a monophasic clinical course (Case 1,
Fig. 1). As previously discussed, they have radiological fea-
tures of a focal, unilateral, proximal occlusive arteriopathy,
indistinguishable from FCA. It has not been routine practice to
undertake exhaustive microbiological investigation or lumbar
punctures in children with AIS, even with a history of prior
VZV. It is well recognized that in many of the latter cases
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VZV DNA is not detected in the CSF [41]; however, data on
VZVantibodies or other infectious biomarkers is scant. This is
in contrast to the literature on VZV vasculitis, an entity largely
described in adults. These patients commonly have recent
herpes zoster and present with more diffuse features such as
headache; a progressive or recurrent course is common. An-
giographic findings are more variable, with a less consistent
pattern of changes, often with multifocal involvement and
involvement of multiple sizes of vessel (Case 2, Fig. 2).
VZV DNA is found in the CSF in about a third but VZV
Fig. 1 Case 1 illustrates the phenotype of varicella-associated AIS. Brain
imaging from a 17 month old boy who presented with an acute L
hemiparesis, having had chickenpox 8 months earlier. (a) coronal FLAIR
images showing high signal in the basal ganglia (caudate and lentiform
nuclei) on the right. (b) 2D time of flight magnetic resonance imaging
showing reduced flow in the distal left M1 segment of the middle cerebral
artery, extending distally. No other AIS risk factors were identified despite
extensive investigation, including echocardiography. A lumbar puncture
was not done and the final diagnosis was post-varicella cerebral infarc-
tion. Hewas treated with aspirin and followed-up until the age of 12 years.
He did not have any further clinical or radiological events and made an
excellent motor recovery with minimal residual L sided motor signs
Fig. 2 Case 2 illustrates the clinical presentation and imaging findings of
varicella vasculitis. Scans from a 7 year old girl who presented with
transient weakness of the right arm 3 months after clinical chickenpox.
This was her first neurologic presentation. Axial T2 weighted MRI scans
(a-c) show infarcts involving the right periventricular white matter and
posterior borderzone region, which had restricted diffusion (a and b) and
an additional lesion with free diffusion in the head of the left caudate (c),
suggesting an older clinically silent event. 2D time of flight MRA (d)
showed a focal area of signal drop-out in the M1 segment of the L
MCA.CSF was acellular and negative for VZV DNA. A diagnosis of
FCA was made and she was treated with aspirin. Three weeks later she
presented with a further episode of transient right-sided weakness. Brain
imaging did not show any further infarcts but catheter cerebral angiogra-
phy (e) L ICA injection, demonstrated more severe and extensive stenosis
of the L MCA. In addition there were bilateral A1 stenoses and unilateral
P1 stenosis. CSF examination was repeated; the CSF remained acellular,
on this occasion positive for VZV DNA low titer, and VZV IgG was
demonstrated to be significantly higher in CSF than in serum. She was
treated with a short course of oral steroids and 3 months of acyclovir
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antibodies in the CSF appear to be a more sensitive diagnostic
test (positive in >90 %). Steroids and acyclovir are recom-
mended in the treatment of VZV vasculitis but are not as yet
routinely advocated in children with post-varicella cerebral
infarction.
VZVassociated arteriopathy could be caused by productive
virus infection in cerebral arteries [42]. Because the interval
between the disease and AIS in children can be as long as 6 or
more months, reactivation of latent VZV and subsequent
infection of brain arteries, or an ongoing process of persistent
silent infection in the brain arteries after the primary infection/
viremia and direct invasion of the arterial wall by the virus,
could explain the association with of AIS. Asymptomatic
VZV reactivation has been demonstrated under stressful con-
ditions, even in immunocompetent individuals [43–46] The
observation that in children in the intensive care unit setting
VZV DNA was more commonly detected in those who had
subclinical primary infection has led to speculation that sub-
clinical chickenpox could be associated with lower levels of
viremia and associated cellular immunity, predisposing these
children to greater risk of reactivation under stress.
An earlier study in which normal andVZVinfected cerebral
and temporal arteries were analyzed histologically and histo-
chemically, has shown the presence of VZV primarily in the
adventitia early in infection and in the media and intima later
[47]. This finding supports the theory that after reactivation
from ganglia, VZV spreads transaxonally to the arterial adven-
titia followed by transmural spread of virus. The authors sug-
gested that stroke in VZVarteriopathymay result from changes
in arterial caliber and contractility produced in part by abnor-
mal accumulation of smooth muscle cells and myofibroblasts
in thickened neointima and disruption of the media. Animal
studies have identified afferent fibers from trigeminal and
dorsal root ganglia to both intracranial and extracranial blood
vessels [48], providing an anatomic pathway for possible
transaxonal spread of virus from the ganglia following reacti-
vation. In addition, pathologic and virological analyses of
cerebral arteries from adult patients who died from VZV
vasculopathy have revealed herpes virions, VZV antigen, and
VZV DNA in the walls of cerebral arteries [49–51].
Much remains unknown about the role of VZV in childhood
AIS and it would appear from the adult VZV vasculitis literature
that the current approach to investigation of even children with a
clear history of VZV is insufficiently detailed. Our current
recommendation would be to undertake comprehensive micro-
biological investigation (including CSF microscopy, PCR for
VZV DNA, oligoclonal bands, and VZV antibodies in blood
and CSF) in all children with AIS and a history of VZV. Our
current practice is to treat patients with VZV DNA or increased
CSF antibody titres with acyclovir and steroids. It is well recog-
nized that VZVinfection can be subclinical and it is possible that
it has a role in childhood AIS where there is no antecedent
history of VZV, but this remains a matter of speculation.
Other Infections Associated with Childhood AIS
Viral Infections
AIS is a well-recognized complication of Human Immunode-
ficiency Virus (HIV); potential mechanisms of infarction are
primary arteriopathy caused by direct HIV-1 infection of the
arterial wall, or secondary because of opportunistic infections,
meningitis, encephalitis, vasculitis, coagulopathy, or cardio-
embolic events [52–54]. The former issue is likely to gain
increasing importance with improvements in the long-term
survival of children with vertically transmitted HIV.
Other viruses have been linked to cerebrovascular disease
and AIS in the published literature but only in case reports or
small case series. Apart from VZV, other herpes viruses have
been associated with childhood cerebral arteriopathies, includ-
ing Epstein Barr virus and Cytomegalovirus (CMV) [54–58].
It has been suggested that CMV plays a role in the pathogen-
esis of arteriosclerotic plaques in cerebral arteries [57]. EBV
has been described as a stimulus for AIS during primary EBV
infection in children in case reports, but EBV DNA appears to
be infrequently detected in CSF in patients with primary EBV
infection, viremia, and neurologic manifestations [55, 58].
Parvovirus B19 has been implicated in childhood AIS as a
co-factor in patients with underlying sickle cell disease [59]; in
a literature review of 81 adult and pediatric cases of neurologic
disease associated with Parvovirus B19 and confirmed by
detection of viral DNA or specific antibodies in CSF, AIS
accounted for approximately 13 % of all central nervous sys-
tem (CNS) manifestations and was described, as previously
mentioned, more commonly in patients with altered immunity
or sickle cell disease with aplastic crisis [60]. Enterovirus has
been associated with focal stenosis of the proximal middle
cerebral artery and presence of enteroviral RNA in cerebrospi-
nal fluid in a case report [61]. Influenza A virus has also been
reported in the context of ischemic stroke in children [62, 63].
Bacterial Infections
Severe bacterial infections as septicemia or meningitis can
lead to cerebral infarction by several mechanisms including
activation of the coagulation cascade, septic emboli, vascular
tissue injury, and inflammation. In bacterial meningitis, the
basal cerebral vessel may be bathed in the purulent exudate,
thus, there is direct spread of inflammation. A prospective
study of 166 children with perinatal and childhood meningitis
identified 14 patients with a concomitant stroke; Salmonella
species and Streptococcus pneumoniae were the most com-
mon causative agents [64].
Mycoplasma pneumoniae has also been reported in relation
to childhood stroke in a number of case reports, in a few cases
confirmed by intrathecal production of antibodies to myco-
plasma pneumoniae or polymerase chain reaction (PCR) in
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the CSF [65–69]. Other bacterial infectious agents described
in the context of pediatric stroke are Borrelia burgdorferi
[70–72] and Hemophilus influenza in the prevaccination era
[73, 74], and Chlamydia pneumoniae. Bandaru et al reported
on a case-control study at single center examining the role of
Chlamydia Pneumoniae infection as a risk factor for AIS in
the young, and showed Chlamydia pneumoniae seropositivity
(IgG) in 27.5 % of the 120 AIS patients vs 12.5 % of the 120
controls [75]. AIS commonly complicates tuberculosis; in a
recent 20-year review of central nervous system manifesta-
tions of tuberculosis, one-third of the children studied had
evidence of a stroke on neuroimaging [76].
Other Infections
AIS associated with fungal infections (eg, Aspergillus,
Candida albicans, Coccidioides immitis, and Cryptococcus
neoformans) are rarely encountered in the immunocompetent
population [77], but may be observed in the immunocompro-
mised. Such children eg, with malignancy, after bone marrow
transplant, or with HIV are encountered not infrequently in
clinical practice in large pediatric units.
In summary, although broad categories of infections have
been shown to be associated with increased stroke risk, fewer
studies have investigated the role of specific pathogens; apart
from the case of VZV, the body of evidence for other infec-
tious pathogens (Table 1) comes mainly from case reports
with very few exceptions. Recognizing the significance of
infections in the development of cerebral arteriopathies and
AIS, an international collaboration has led to a prospective
study investigating the vascular effects of infection in pediat-
ric stroke (VIPS). The VIPS study, which has recently finished
recruiting, will measure association between markers of infec-
tion and cerebral arteriopathy and will assess whether cerebral
arteriopathy and inflammatory markers predict recurrent
stroke [78].
The Role of Trauma in Childhood Arterial Ischemic
Stroke
As discussed in the introduction, several single center studies
identified prior head and neck trauma in association with
childhood AIS. Initial observations were met with a degree
of skepticism about whether traumawas the precipitant of AIS
or reflected its motor sequelae. Compelling recent, population
based, data is from the previously mentioned Northern Cali-
fornian study, which showed that head/neck trauma in the
previous 12 weeks was prevalent and strongly associated with
AIS [79]. Multiple potential mechanisms are implicated. Pick-
ing up on the theme between genetic predisposition and
environmental precipitant, experimental models of some
monogenic diseases associated with childhood stroke, specif-
ically mutations in COL4A1 and neurofibromatosis type 1
suggest that trauma is a necessary cofactor to the genetic
predisposition in order to produce stroke. The disease path-
ways implicated relate to abnormal vessel wall integrity,
smooth muscle proliferation or response to injury [3]. As
previously discussed trauma is also a potent instigator of an
inflammatory response.
Several specific clinical phenotypes link trauma and child-
hood AIS. One is that of basal ganglia infarction in young
children after minor head injury. This is a distinctive pheno-
type in clinical practice, with a monophasic course and largely
favorable outcomes [80–82]. It has been postulated that the
underlying mechanism is that of vasospasm of the
lenticulostriate perforators for, as yet, unidentified reasons.
A recent series has described a group of children with minor
Table 1 Infectious agents in
childhood stroke and diagnosis Infectious agent Specific CSF investigations
Varicella zoster virus VZV DNA, intrathecal antibodies
Herpes simplex virus type-1 HSV-1 DNA, intrathecal antibodies
Epstein Barr virus EBV DNA, intrathecal antibodies
Cytomegalovirus CMV DNA, intrathecal antibodies
Enterovirus Enteroviral RNA
Mycoplasma pneumoniae Intrathecal antibodies, polymerase chain reaction
Parvovirus B19 Intrathecal antibodies, polymerase chain reaction
Borrelia burgdorferi Intrathecal antibodies
Influenza virus Polymerase chain reaction
Mycobacterium tuberculosis Culture, immunoblotting, polymerase chain reaction
Hemophilus influenzae Polymerase chain reaction, intrathecal antibodies
Chlamydia pneumoniae Intrathecal antibodies, polymerase chain reaction
Salmonella, Streptococcus pneumoniae - meningitis Culture, polymerase chain reaction (16 s PCR)
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head trauma, basal ganglia infarction and evidence of a min-
eralizing angiopathy of the lenticulostriate perforators appar-
ent on CT [80, 81]. It is intriguing to speculate why such cases
have not been widely reported before; one possible explana-
tion is that most children with AIS are now generally investi-
gated with magnetic resonance imaging rather than CT and of
childhood AIS cases overall, this group represents a small
minority. Several mechanisms have been postulated, for ex-
ample mechanical stretching of the mineral ized
lenticulostriate arteries during trauma, a pre-existing neonatal
lenticulostriate vasculopathy and congenital or very early
childhood infections (CMV, EBV,Mycoplasma) as precursors
of mineralization, suggesting that trauma may not be a cause,
but a trigger for occlusion of predisposed vessels [81, 82].
The relationship between trauma and cervical arterial dis-
section is well-recognized [11, 83, 84]. However, in clinical
practice, many cases are nontraumatic. A number of patients
have underlying inherited connective tissue disorders includ-
ing Ehlers-Danlos syndrome (type IV), homocystinuria, arte-
rial tortuosity syndrome, and occasionally Marfan syndrome
and pseudoxanthoma elasticum [85]. However, a larger group
of patients have evidence of more subtle degrees connective
tissue abnormality, apparent only on electron microscopy of
skin [86, 87]. In addition, infection has been shown to be a risk
factor for arterial dissection, another mechanism linking in-
fection and arteriopathy [88].
Intracranial arterial dissection is a more controversial diag-
nostic entity. At a radiological level, particularly with MRA,
published cases are indistinguishable from FCA but in a few
such cases there has been histologic evidence of intracranial
dissection [89]. Even on catheter angiography pathognomonic
features (dissection flap, pseudoaneurysm) may not always be
apparent.
Conclusions
Childhood stroke is an important cause of long-term neuro-
logic morbidity in the young. In contrast to adults, risk factors
and disease mechanisms for arterial ischemic stroke are di-
verse. Current hypotheses about causation suggest interaction
between host predisposition (possibly genetically mediated)
and secondary insults, often environmental. Of these, infec-
tion and trauma are associated, probably by their effect on the
cerebral circulation. Current research is focused on examining
these interactions in large groups but also on the role of
specific pathogens like Varicella Zoster virus. Such work is
likely to impact on prevention, treatment and outcome.
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